Iovance Biotherapeutics, Inc. (IOVA) KPIs and segments
Close on Nov 17, 2026Market cap $3.41BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Iovance Biotherapeutics's business
Iovance Biotherapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amtagvi($M) | 90.7 | 60.2 | 64.9 | 57.5 | 54.1 | 43.6 | 48.7 | 42.0 | 12.8 | ||||
Proleukin($M) | 8.59 | 11.2 | 21.9 | 9.97 | 5.88 | 5.75 | 25.0 | 16.5 | 18.3 | 0.72 | 0.48 | 0.47 | |
Earlier reporting (last reported 2023)1 | |||||||||||||
United States($M) | 99.0 | 70.5 | 85.5 | 66.4 | 58.6 | 48.5 | 73.2 | 57.8 | 30.0 | 0 | 0 | 0 | |
Non-US($M) | 0.35 | 0.96 | 1.29 | 1.05 | 1.35 | 0.80 | 0.50 | 0.74 | 1.07 | 0.72 | 0.48 | 0.47 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-06.
See a number that looks wrong?